Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers

R. W. Norman, D. S. Scurr, W. G. Robertson, Munro Peacock

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In vitro studies showed that sodium pentosan polysulphate (SPP) is an active inhibitor of calcium oxalate (CaOx) crystal growth and agglomeration and that it acts by increasing the negative zeta potential on the surface of CaOx crystals. Oral administration of SPP to control subjects, recurrent stone formers and patients with primary hyperoxaluria resulted in an overall increase of 8% (P <0.01) in the polyanionic inhibition of CaOx crystallisation in urine as measured by the zeta potential. SPP could provide a novel approach to the medical prevention of recurrent CaOx stone disease.

Original languageEnglish (US)
Pages (from-to)594-598
Number of pages5
JournalBritish Journal of Urology
Volume56
Issue number6
StatePublished - 1984
Externally publishedYes

Fingerprint

Pentosan Sulfuric Polyester
Calcium Oxalate
Crystallization
Primary Hyperoxaluria
Oral Administration
Urine

ASJC Scopus subject areas

  • Urology

Cite this

Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers. / Norman, R. W.; Scurr, D. S.; Robertson, W. G.; Peacock, Munro.

In: British Journal of Urology, Vol. 56, No. 6, 1984, p. 594-598.

Research output: Contribution to journalArticle

@article{000ea15fe87247aabca6a273e0a96b27,
title = "Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers",
abstract = "In vitro studies showed that sodium pentosan polysulphate (SPP) is an active inhibitor of calcium oxalate (CaOx) crystal growth and agglomeration and that it acts by increasing the negative zeta potential on the surface of CaOx crystals. Oral administration of SPP to control subjects, recurrent stone formers and patients with primary hyperoxaluria resulted in an overall increase of 8{\%} (P <0.01) in the polyanionic inhibition of CaOx crystallisation in urine as measured by the zeta potential. SPP could provide a novel approach to the medical prevention of recurrent CaOx stone disease.",
author = "Norman, {R. W.} and Scurr, {D. S.} and Robertson, {W. G.} and Munro Peacock",
year = "1984",
language = "English (US)",
volume = "56",
pages = "594--598",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers

AU - Norman, R. W.

AU - Scurr, D. S.

AU - Robertson, W. G.

AU - Peacock, Munro

PY - 1984

Y1 - 1984

N2 - In vitro studies showed that sodium pentosan polysulphate (SPP) is an active inhibitor of calcium oxalate (CaOx) crystal growth and agglomeration and that it acts by increasing the negative zeta potential on the surface of CaOx crystals. Oral administration of SPP to control subjects, recurrent stone formers and patients with primary hyperoxaluria resulted in an overall increase of 8% (P <0.01) in the polyanionic inhibition of CaOx crystallisation in urine as measured by the zeta potential. SPP could provide a novel approach to the medical prevention of recurrent CaOx stone disease.

AB - In vitro studies showed that sodium pentosan polysulphate (SPP) is an active inhibitor of calcium oxalate (CaOx) crystal growth and agglomeration and that it acts by increasing the negative zeta potential on the surface of CaOx crystals. Oral administration of SPP to control subjects, recurrent stone formers and patients with primary hyperoxaluria resulted in an overall increase of 8% (P <0.01) in the polyanionic inhibition of CaOx crystallisation in urine as measured by the zeta potential. SPP could provide a novel approach to the medical prevention of recurrent CaOx stone disease.

UR - http://www.scopus.com/inward/record.url?scp=0021736239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021736239&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 594

EP - 598

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 6

ER -